Erlotinib Completed Phase 2 Trials for Stage IV Breast Cancer / Triple-Negative Breast Cancer (TNBC) / Progesterone Receptor-negative Breast Cancer / Estrogen Receptor-negative Breast Cancer / HER2-Negative Breast Cancer / Recurrent Breast Cancer Treatment